Pneumococcal vaccine conjugate 10-valent - GlaxoSmithKline

Drug Profile

Pneumococcal vaccine conjugate 10-valent - GlaxoSmithKline

Alternative Names: 10-valent pneumococcal conjugate vaccine - GlaxoSmithKline; 10-valent pneumococcal vaccine conjugate - GlaxoSmithKline; 10Pn-PD-DiT; GSK-1024850A; PHiD-CV; Pneumococcal 10-valent vaccine conjugate - GlaxoSmithKline; Streptorix™; Synflorix

Latest Information Update: 24 Mar 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Conjugate-vaccines; Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Otitis media; Pneumococcal infections
  • Registered Pneumonia

Most Recent Events

  • 18 Oct 2017 GlaxoSmithKline receives World Health Organization prequalification for four-dose vial of 10-valent pneumococcal conjugate vaccine
  • 27 Jun 2017 GSK receives CHMP positive opinion for Pneumococcal vaccine conjugate 10-valent four-dose vial
  • 28 Apr 2017 Menzies School of Health Research completes a phase II/III trial in Pneumococcal infections (prevention in infants) in Vietnam (NCT01953510)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top